Membrane proteins are the gateway to cells and are involved in many critical functions. Each membrane protein is unique, and their complexity makes it difficult to fit into a standardized expression ...

Cambridge, UK and Marlborough, MA, 28 May 2025: Nuclera, the biotechnology company accelerating protein expression and optimization through its benchtop eProtein Discovery™ System, has announced a ...

Membrane proteins are vital for cellular signaling, transport, and communication, making them attractive drug targets despite their challenging properties. Advances in mass spectrometry have enabled ...

Nuclera (Cambridge, UK) is a biotech company that specializes in rapid protein expression and purification optimization at the benchtop. With the aim of streamlining the drug discovery process, ...

Microbial systems offer distinct advantages in protein expression, saving costs and time, and offering well-characterized host genetics and ease of scale-up. 2 However, challenges remain in process ...

Nuclera extended its Series C with $12M, bringing total to $87M, to expand Protein Discovery with full-format antibody ...

Researchers at Nuclera completed the first Asian installations of its eProtein Discovery System at National Taiwan University ...

Abselion has expanded its Amperia™ platform with a Tagged Protein Quantification Kit | His-tag and a Tagged Protein Sensor | His-tag Quantification, developed in collaboration with GenScript.

Focusing on the establishment of Sino Biological‘s Center for Bioprocessing (C4B) in Houston, it highlights how the ...